Phase Ii Clinical Study Of Concurrent Durvalumab And Radiation Therapy (Duart) Followed By Adjuvant Durvalumab In Patients With Localized Urothelial Cancer Of Bladder: Results For Primary Analyses And Survival. Btcrc-Gu15-023.

Monika Joshi,Matthew Kaag,Leonard Tuanquin,Jason Liao,Deepak Kilari,Hamid Emamekhoo,Alexander Sankin,Suzanne B Merrill,Hong Zheng,Sheldon L. Holder,Joshua Warrick,Ralph J. Hauke,Benjamin Adam Gartrell,Mark N. Stein,Joseph J. Drabick,David Degraff,Yousef Zakharia

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用 11|浏览14

暂无评分

摘要

398Background: Bladder cancer (BC) patients (pts) who are cisplatin ineligible/unfit for surgery, or locally advanced and unresectable have limited treatment options. DUART investigates if the comb...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要